The association with tau rather than amyloid pathology confirms recently published results by Leonenko et al. (2019a) showing that amyloid pathology is mainly driven by APOE genotype and that polygenic risk contributes to risk further conversion to Alzheimer’s disease. The gene discussed is MAPT; the disease is Alzheimer disease.